e-learning
resources
Munich 2006
Wednesday 06.09.2006
In vivo
and
in vitro
aspects of lung injury
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Advanced glycation endproducts (AGE) contribute to the expression of pro-fibrotic cytokines and collagen production in a cell type dependent manner
M. A. Queisser, M. Wygrecka, F. M. Kouri, K. T. Preissner (Giessen, Germany)
Source:
Annual Congress 2006 -
In vivo
and
in vitro
aspects of lung injury
Session:
In vivo
and
in vitro
aspects of lung injury
Session type:
Poster Discussion
Number:
4747
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. A. Queisser, M. Wygrecka, F. M. Kouri, K. T. Preissner (Giessen, Germany). Advanced glycation endproducts (AGE) contribute to the expression of pro-fibrotic cytokines and collagen production in a cell type dependent manner. Eur Respir J 2006; 28: Suppl. 50, 4747
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Soluble RAGE is deficient in neutrophilic asthma and COPD
Source: Eur Respir J 2012; 39: 721-729
Year: 2012
A role of the advanced glycation end products (AGEs) in epithelial-myofibroblast transition
Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis
Year: 2010
Reduced soluble receptor for advanced glycation end-products in COPD
Source: Eur Respir J 2011; 37: 516-522
Year: 2011
Soluble receptor for advanced glycation end products (sRAGE) in asthmatic children as a new marker of the disease control
Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma
Year: 2021
Late Breaking Abstract - Increased advanced glycation end-products (AGEs) accumulation in skin is a risk factor lung function deterioration in asthmatic patients- preliminary data
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019
Loss of receptor for advanced glycation end products (RAGE) in idiopathic pulmonary fibrosis
Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair
Year: 2007
Plasma advanced glycation end-products and skin autofluorescence are increased in COPD
Source: Eur Respir J 2014; 43: 430-438
Year: 2013
Regulation of human adult primary alveolar type II cell surfactant protein production by epithelial growth factors and pro-inflammatory cytokines
Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation
Year: 2009
Measures of lung function and their relationship with advanced glycation end-products
Source: ERJ Open Res, 6 (2) 00356-2019; 10.1183/23120541.00356-2019
Year: 2020
Anti-tumorigenic effect of age-/diabetes-related advanced glycation end-products in lung carcinoma
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012
Suppression of discoidin domain receptor 1 by RNA interference attenuates lung inflammation
Source: Annual Congress 2006 - Cellular immunology in asthma pathogenesis
Year: 2006
CCL5 (RANTES) inhibits TGF-β1-induced collagen production in human bronchial epithelial cells by action of Smad protein
Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Year: 2009
Interferon-gamma (IFN-γ) alters the expression of IP-10 and IL-18 in human aveolar epithelial cells type II. Possible role in the reinforcement of Th1-dominated lung inflammation
Source: Eur Respir J 2001; 18: Suppl. 33, 521s
Year: 2001
Activation of TLR3 augments myofibroblasts differentiation and extracellular matrix production
Source: Annual Congress 2009 - Lung cell biology and immunology
Year: 2009
Influence of heparin binding protein (HBP) on pro-inflammatory signal transduction and ICAM-1 expression in A549 cells
Source: Eur Respir J 2004; 24: Suppl. 48, 100s
Year: 2004
Nasal tolerance promotes increase in tumoral type V collagen protein synthesis and vascular apoptosis in the mouse lung chemical carcinogenesis
Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease
Year: 2010
Late-breaking abstract: Activation of the macrophage inflammasome by TLR3 ligation potentiates release of IL-8 and IP-10 from alveolar type II epithelial cells via a paracrine cytokine network
Source: Annual Congress 2011 - Epithelial cells: role in health and disease
Year: 2011
Role of TGF-b1 in type I collagen production in bronchial epithelial cells: effects on Smad7 inhibitory role?
Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies
Year: 2008
Heme oxygenase–1 induced by quercetin attenuates TGF-β-stimulated collagen production in fibroblasts
Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis
Year: 2011
Composition of the cellular matrix, nutrition, and hypoxia modulate the secretion and activation of collagenases and their inhibitors in human lung cells
Source: Eur Respir J 2001; 18: Suppl. 33, 244s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept